Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A

ClinicalTrials.gov ID: NCT02027779

Public ClinicalTrials.gov record NCT02027779. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 24, 2026, 6:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open Label Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A

Study identification

NCT ID: NCT02027779
Recruitment status: Not listed
Study type: Interventional
Phase: Phase 3
Lead sponsor: Green Cross Corporation; Industry
Enrollment: 150 participants

Conditions and interventions

Conditions

Hemophilia A

Interventions

GreenGene™ F Biological

Biological

Eligibility (public fields only)

Age range: Not listed
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 31, 2013
Primary completion: Nov 30, 2015
Completion: Jan 31, 2016
Last update posted: Jan 5, 2014

2014 – 2016

United States locations

U.S. sites: 2
U.S. states: 2
U.S. cities: 2

Facility	City	State	ZIP	Site status
Arkansas Children's Hospital	Little Rock	Arkansas	72202	Recruiting
Long Island Jewish Medical Center - Hemophilia Treatment Center	New Hyde Park	New York	11040	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02027779, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 5, 2014 · Synced Jul 24, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02027779 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →